Found: 26
Select item for more details and to access through your institution.
Waldenstrom's Macroglobulinemia: An Update.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2018, v. 10, n. 1, p. 1, doi. 10.4084/MJHID.2018.004
- By:
- Publication type:
- Article
Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia.
- Published in:
- Biologics: Targets & Therapy, 2015, v. 9, p. 75, doi. 10.2147/BTT.S60503
- By:
- Publication type:
- Article
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 353, doi. 10.1111/bjh.18696
- By:
- Publication type:
- Article
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
- By:
- Publication type:
- Article
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1504, doi. 10.3390/cancers15051504
- By:
- Publication type:
- Article
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3240, doi. 10.3390/cancers13133240
- By:
- Publication type:
- Article
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1837, doi. 10.3390/cancers13081837
- By:
- Publication type:
- Article
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 896, doi. 10.3390/cancers11070896
- By:
- Publication type:
- Article
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221127550
- By:
- Publication type:
- Article
Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association data.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 4, p. 222, doi. 10.1177/2040620716648567
- By:
- Publication type:
- Article
Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 231, doi. 10.1016/j.clml.2013.02.011
- By:
- Publication type:
- Article
Should Patients with Waldenström Macroglobulinemia Receive a BTK Inhibitor as Frontline Therapy?
- Published in:
- Hemato, 2022, v. 3, n. 4, p. 689, doi. 10.3390/hemato3040046
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: What is Fitness in the Era of Targeted Agents?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 356, doi. 10.1016/j.clml.2021.11.009
- By:
- Publication type:
- Article
CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S323, doi. 10.1016/S2152-2650(21)01761-4
- By:
- Publication type:
- Article
Poster: CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01394-X
- By:
- Publication type:
- Article
LDH as Predictive Parameter in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S213, doi. 10.1016/j.clml.2018.07.075
- By:
- Publication type:
- Article
Bing Neel Syndrome in a Previously Untreated Patient With Waldenström's Macroglobulinemia: Contribution of MYD88 L265P Mutation on Cerebrospinal Fluid.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 195, doi. 10.1007/s00280-008-0905-5
- By:
- Publication type:
- Article
Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 621, doi. 10.1002/hon.3122
- By:
- Publication type:
- Article
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 567, doi. 10.1002/hon.3080
- By:
- Publication type:
- Article
Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 1100, doi. 10.1002/hon.3032
- By:
- Publication type:
- Article
Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience.
- Published in:
- 2020
- By:
- Publication type:
- clinical trial
Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients.
- Published in:
- Hematological Oncology, 2009, v. 27, n. 3, p. 148, doi. 10.1002/hon.889
- By:
- Publication type:
- Article
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. 1193, doi. 10.1002/ajh.25600
- By:
- Publication type:
- Article
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 529, doi. 10.1002/ajh.24714
- By:
- Publication type:
- Article
Monoclonal Antibodies in Chronic Lymphocytic Leukemia.
- Published in:
- Lymphoma & Chronic Lymphocytic Leukemias, 2016, n. 6, p. 1, doi. 10.4137/LCLL.S18491
- By:
- Publication type:
- Article